Journal Home > Volume 11 , Issue 4

In this work, the application of silver nanoparticles (Ag NPs) for spectrophotometric determination of cefdinir (CFD) and cefepime HCl (CFP) was developed. The method was based on the ability of the alkaline degradation products of the cited drugs to reduce Ag+ ions to silver nanoparticles (Ag-NPs) in the presence of gelatin as a capping agent. The linear concentration ranges were 5.0-40 and 10-100 μg/mL for cefdinir and cefepime HCl, respectively. The lower detection limits were found to be 0.39 and 1.06 μg/mL for CFD and CFP, respectively, while the quantitation limits were found to be 1.18 and 3.21 μg/mL for CFD and CFP, respectively. The formed nanoparticles were characterized by ultraviolet-visible spectroscopy and transmission electron microscopy. The proposed method was applied successfully to determination of CFD and CFP in pure drugs, pharmaceutical preparations and human urine samples.


menu
Abstract
Full text
Outline
About this article

Application of Silver Nanoparticles for the Spectrophotometric Determination of Cefdinir and Cefepime HCl in Pharmaceutical Preparations and Human Urine Samples

Show Author's information Walaa El-Alfy( )Omnia Ahmed IsmaielMagda Youssef El-MammliAbdalla Shalaby
Department of Analytical Chemistry, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt

Abstract

In this work, the application of silver nanoparticles (Ag NPs) for spectrophotometric determination of cefdinir (CFD) and cefepime HCl (CFP) was developed. The method was based on the ability of the alkaline degradation products of the cited drugs to reduce Ag+ ions to silver nanoparticles (Ag-NPs) in the presence of gelatin as a capping agent. The linear concentration ranges were 5.0-40 and 10-100 μg/mL for cefdinir and cefepime HCl, respectively. The lower detection limits were found to be 0.39 and 1.06 μg/mL for CFD and CFP, respectively, while the quantitation limits were found to be 1.18 and 3.21 μg/mL for CFD and CFP, respectively. The formed nanoparticles were characterized by ultraviolet-visible spectroscopy and transmission electron microscopy. The proposed method was applied successfully to determination of CFD and CFP in pure drugs, pharmaceutical preparations and human urine samples.

Keywords: Silver nanoparticles, Cefdinir, Cefepime HCl, Human urine samples

References(45)

[1]
United States Pharmacopoeia (USP) 36 National Formulary 31, US pharmacopieal convention. Rockville MD, 2013: 2850-2855.
[2]
S.C. Sweetman, Martindale: The complete drug reference, 36th ed., Vol. A. The Pharmaceutical Press, 2009: 223-224.
[3]

D.R. Guay, Cefdinir: An expanded-spectrum oral cephalosporin. Annals of Pharmacotherapy, 2000, 34(12): 1469-1477.

[4]

J.M.T. Chimatapu, H.S. Venkataramana, Extractive spectrophotometric method development and validation of cefepime hydrochloride in tablet formulation. World Journal of Pharmacy and Pharmaceutical Sciences, 2018, 7(7): 688-696.

[5]

M.A.B. Lara, F. Tutunji, S. Shilbayeh, et al., Determination of cefdinir in human plasma using HPLC coupled with tandem mass spectroscopy: Application to bioequivalence studies. Jordan Journal of Pharmaceutical Sciences, 2015, 8(2): 123-139.

[6]

H.E. Jin, I.B. Kim, C.K. Kim, et al., Determination of cefdinir levels in rat plasma and urine by high-performance liquid chromatography–tandem mass spectrometry: application to pharmacokinetics after oral and intravenous administration of cefdinir. Biomedical Chromatography, 2013, 27(11): 1423-1430.

[7]

O. Abdel-Aziz, M. Farouk, R. Nagi, et al., Simple spectrophotometric and HPTLC densitometric methods for determination of cefdinir in bulk powder and pharmaceuticals, and in presence of its hydrolytic degradation products. Journal of Applied Pharmaceutical Science, 2014, 4(7): 129.

[8]

N.H. Abou-Taleb, D.R. El-Wasseef, D.T. El-Sherbiny, et al., Optimizing the spectrofluorimetric determination of cefdinir through a Taguchi experimental design approach. Luminescence, 2016, 31(3): 856-864.

[9]

İ. H. Taşdemir, Electrochemistry and determination of cefdinir by voltammetric and computational approaches. Journal of Food and Drug Analysis, 2014, 22(4): 527-536.

[10]

S.A. Al-Ameri, Application of DPP for the determination of cefdinir in pharmaceuticals. Glob J Sci Front Res B Chem, 2017, 17(1): 27-32.

[11]

H. Liu, V.B. Sunderland, Validated method for simultaneous determination of cefepime and l‐arginine in cefepime for injection by capillary zone electrophoresis. Journal of Liquid Chromatography & Related Technologies, 2004, 27(19): 3065-3076.

[12]

D.F. Rodrigues, H.R.N. Salgado, Development and validation of a green analytical method of RP-HPLC for quantification of cefepime hydrochloride in pharmaceutical dosage form: Simple, sensitive and economic. Current Pharmaceutical Analysis, 2016, 12(4): 306-314.

[13]

B. Shrestha, N.R. Bhuyan, and B.N. Sinha, Simultaneous determination of cefepime and tazobactam in injectables by ultra-high performance liquid chromatography method. Pharmaceutical Methods, 2014, 5(1): 20-26.

[14]

Y.H. Yang, W.Y. Wu, H.H. Yeh, et al., Simultaneous determination of cefepime and vancomycin in plasma and cerebrospinal fluid by MEKC with direct sample injection and application for bacterial meningitis. Electrophoresis, 2007, 28(11): 1788-1797.

[15]

Y.R. Chen, S.J. Lin, Y.W. Chou, et al., Simultaneous determination of cefepime and L-arginine by micellar electrokinetic chromate-graphy and applications to commercial injections. Journal of Separation Science, 2005, 28(16): 2173-2179.

[16]

H.-H. He, P. Yu, and K.-N. Huang, Determination of N-methylpyrrolidine in cefepime by GC. Chinese Journal of Antibiotics, 2007, 32(2): 87.

[17]

M.A. Farajzadeh, L. Goushjuii, and Y. Bashour, A simple and rapid dispersive liquid–liquid microextraction method followed by GC-FID for determination of N-methylpyrrolidine in cefepime. Journal of Separation Science, 2010, 33(23‐24): 3767-3773.

[18]

M. Dąbrowska, M. Starek, J. Krzek, et al., A degradation study of cefepime hydrochloride in solutions under various stress conditions by TLC–densitometry. Biomedical Chromatography, 2015, 29(3): 388-395.

[19]

M.S.M. Dąbrowska, J. Krzek, E. Papp, et al., A degradation study of cefepime hydrochloride in solutions under various stress conditions by TLC-densitometry. Biomedical Chromatography, 2015, 29(3): 388-395.

[20]

Y. Jin, Y.-P. Hand, and C.-Y. Yang, Determination of N-methylpyrrolidine in cefepime dihydrochloride by ion chromatography with conductivity detector. Chinese Journal of Pharmaceuticals, 2009, 7: 19.

[21]

J.-S. Liu, Y.-Q. Cai, Determination of N-methylpyrrolidine in cefepime hydrochloride by ion chromatography. Chinese Journal of Analysis Laboratory, 2007, 3.

[22]

M.S. Elazazy, A.A. Shalaby, Validated spectrophotometric assay of cefepime hydrochloride and cefuroxime sodium using a tetrazolium salt. Journal of Chemistry, 2012, 9(4): 2261-2267.

[23]

S.A. Weshahy, N.Y. Hassan, N.M. Mostafa, et al., Development and validation of spectrophotometric, chemometric and highpressure liquid chromatographic methods for the determination of cefepime hydrochloride in the presence of its acid and alkaline degradation products. International Journal of Analytical and Bioanalytical Chemistry, 2013, 3: 86-96.

[24]

S.M. Derayea, H.M. Ahmed, O.H. Abdelmageed, et al., New valid spectrofluorimetric method for determination of selected cephalosporins in different pharmaceutical formulations using safranin as fluorophore. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2016, 153: 655-660.

[25]

N.M. Mostafa, L. Abdel-Fattah, S.A. Weshahy, et al., Stability-indicating spectrofluorometric method for the determination of some cephalosporin drugs via their degradation products. Journal of AOAC International, 2015, 98(2): 361-370.

[26]

F.J. Jiménez Palacios, M. Callejón Mochón, J.C. Jiménez Sánchez, et al., Adsorptive stripping voltammetric determination of cefepime at the mercury electrode in human urine and cerebrospinal fluid, and differential pulse polarographic determination in serum. Journal of Pharmaceutical Sciences, 2003, 92(9): 1854-1859.

[27]

A. Al-Attas, J.J. Nasr, N. El-Enany, et al., A green capillary zone electrophoresis method for the simultaneous determination of piperacillin, tazobactam and cefepime in pharmaceutical formulations and human plasma. Biomedical Chromatography, 2015, 29(12): 1811-1818.

[28]

S.J. Prasanna, H.K. Sharma, K. Mukkanti, et al., Validation of capillary electrophoresis method for determination of N-methylpyrrolidine in cefepime for injection. Journal of Chromatographic Science, 2010, 48(10): 830-834.

[29]

S.-Q. Zhang, Flow injection chemiluminescence method for the determination of cefepime hydrochloride based on NBS-fluorescein reaction. Chemical Research and Application, 2007, 19(1): 118.

[30]

S. Gurunathan, Rapid biological synthesis of silver nanoparticles and their enhanced antibacterial effects against Escherichia fergusonii and Streptococcus mutans. Arabian Journal of Chemistry, 2019, 12(2): 168-180.

[31]

R. Foulkes, M. Ali Asgari, A. Curtis, et al., Silver-nanoparticle-mediated therapies in the treatment of pancreatic cancer. ACS Applied Nano Materials, 2019, 2(4): 1758-1772.

[32]

D. Chen, X. Qiao, X. Qiu, et al., Synthesis and electrical properties of uniform silver nanoparticles for electronic applications. Journal of Materials Science, 2009, 44(4): 1076-1081.

[33]

A. Taleb, V. Russier, A. Courty, et al., Collective optical properties of silver nanoparticles organized in two-dimensional superlattices. Physical Review B, 1999, 59(20): 13350.

[34]

E.S. Hesham Salem, Determination of cefotaxime, cefoperazone, ceftazidime and cefadroxil using surface plasmon resonance band of silver nanoparticles. Brazilian Journal of Pharmaceutical Sciences, 2018, 54(3).

[35]

H.R.H.A. Sayed, M. Derayea, A.A. Hamad, et al., Application of silver nanoparticles for the spectrophotometric determination of three benzimidazole anthelmintic drugs in their pharmaceutical preparations. Journal of Applied Pharmaceutical Science, 2017, 7(2): 76-82.

[36]

S.A. Morteza Bahram, T. Madrakian, Application of silver nanoparticles for simple and rapid spectrophotometric determination of acetaminophen and gentamicin in real samples. Sensor Letters, 2015, 13: 1-7.

[37]

M.F. Ali, M.A. Marzouq, B.I. Salman, et al., Utility of surface plasmon resonance response of silver nanoparticles for assay of Teicoplanin in human plasma using spectrofluorimetric technique. Microchemical Journal, 2019, 146: 187-191.

[38]

M. Khoubnasabjafari, R. Salari, A. Samadi, et al., Colorimetric determination of phenytoin using indoxyl sulfate capped silver nanoparticles. Analytical Methods, 2019, 11: 3324-3330.

[39]

H. Salem, A.A. Elhela, and N.M. Abdelhady, Utility of silver nanoparticles for the analysis of diosmin and rutin in Persicaria salicifolia extract. Authentic and pharmaceutical dosage forms monitored with their haemostatic activity. African Journal of Pharmacy and Pharmacology, 2018, 12(20): 248-262.

[40]

A. Anwar, M. Shah, S. Muhammad, et al., Synthesis of 4-formyl pyridinium propylthioacetate stabilized silver nanoparticles and their application in chemosensing of 6-aminopenicillanic acid (APA). International Journal of Environmental Science and Technology, 2019, 16(3): 1563-1570.

[41]

M. Bin Ahmad, J.J. Lim, K. Shameli, et al., Synthesis of silver nanoparticles in chitosan, gelatin and chitosan/gelatin bionanocomposites by a chemical reducing agent and their characterization. Molecules, 2011, 16(9): 7237-7248.

[42]

M. Gioffrè, P. Torricelli, S. Panzavolta, et al., Role of pH on stability and mechanical properties of gelatin films. Journal of Bioactive and Compatible Polymers, 2012, 27(1): 67-77.

[43]

Technical requirments for registeration of pharmaceuticals for human use. Proceedings of International Conference on Harmonisation, ICH, 2005.  

[44]

K.P.R. Sundararajan, Analytical method development and validation of cefdinir in bulk and pharmaceutical dosage form by UV-visible spectrophotometric method. European Journal of Biomedical and Pharmaceutical Sciences, 2017, 4(12): 646-651.

[45]

G.B.A.K. Chavala, N.S. Sama, and K.V.R. Prasanth, Spectrophotometric determination some cephalosporins containing amino group using 1, 2-napthaquinone-4-sulfonic acid sodium in pharmaceutical dosage form. International Journal of Pharmacy & Technology, 2011, 3(1): 1750-1767.

Publication history
Copyright
Acknowledgements
Rights and permissions

Publication history

Received: 19 July 2019
Accepted: 27 November 2019
Published: 13 December 2019
Issue date: December 2019

Copyright

© GhWalaa El-Alfy, Omnia Ahmed Ismaiel, Magda Youssef El-Mammli, and Abdalla Shalaby.

Acknowledgements

This work was supported by Department of Analytical Chemistry, Faculty of Pharmacy, Zagazig University, Egypt. The authors wish to express their gratitude for the support of this work.

Rights and permissions

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Return